Fouzia Laghrissi-Thode
CIK: 0001642015
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Minerva Neurosciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 3, 2026NERV
Minerva Neurosciences, Inc.
Award(A)DirectStock Option (right to buy)
50K shares- - Dec 22, 2025NERV
Minerva Neurosciences, Inc.
Award(A)DirectStock Option (right to buy)
50K shares- - Dec 5, 2024NERV
Minerva Neurosciences, Inc.
Award(A)DirectStock Option (right to buy)
12.5K shares-
1-3 of 3 transactions
About Laghrissi-Thode Fouzia
Laghrissi-Thode Fouzia (SEC CIK 0001642015) files insider reports with the SEC as Director of Minerva Neurosciences, Inc. (NERV).
Signal8 holds 3 ownership filings by Laghrissi-Thode Fouzia, all Form 4s, filed between Dec 6, 2024 and Jun 5, 2026. Those filings report 3 transactions, from Dec 5, 2024 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Laghrissi-Thode Fouzia's filings is in BURLINGTON, MA.
Recent filings by Laghrissi-Thode Fouzia
Other insiders filing for Minerva Neurosciences, Inc. (NERV)
- Kaul Inderjit, Director
- Reilly Joseph H., Chief Operating Officer
- Aliquo Anthony, Chief Accounting Officer
- Ahlholm Frederick W, SVP, CFO and Secretary
- Luthringer Remy, CEO
- Kupfer David, Director